Halozyme Therapeutics Inc (NASDAQ:HALO)

15.12
Delayed Data
As of May 05
 -0.57 / -3.63%
Today’s Change
6.95
Today|||52-Week Range
17.27
+56.68%
Year-to-Date

Today’s Trading

Previous close15.69
Today’s open15.63
Day’s range-- - --
Volume1,320,789
Average volume (3 months)1,431,632
Market cap$2.0B
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+10.25%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book47.70

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.38-4.73%
ESPREsperion Therapeutic...-6.85-6.60%
OPHTOphthotech Corp-1.81-3.80%
KITEKite Pharma Inc-0.51-0.94%
Data as of 05/05/2015

Financials

Next reporting dateMay 8, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers